within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01B_PosteriorPituitaryLobeHormones.H01BA03_Lypressin;

model Lypressin
  extends Pharmacolibrary.Drugs.ATC.H.H01BA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H01BA03</td></tr><td>route:</td><td>intranasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lypressin (lysine vasopressin) is a synthetic analogue of the natural antidiuretic hormone vasopressin, previously used to treat diabetes insipidus, particularly central diabetes insipidus. It acts as a replacement for ADH deficiency by promoting water reabsorption in the renal collecting ducts. Lypressin is no longer widely used, having been replaced by desmopressin for this indication.</p><h4>Pharmacokinetics</h4><p>No peer-reviewed clinical pharmacokinetic studies specifically reporting parameters for lypressin in humans could be identified. The following are estimated pharmacokinetic values based on general vasopressin analogues and known properties.</p><h4>References</h4><ol><li><p>Baena-Cagnani, CE (2004). Safety and tolerability of treatments for allergic rhinitis in children. <i>Drug safety</i> 27(12) 883–898. DOI:<a href=\"https://doi.org/10.2165/00002018-200427120-00005\">10.2165/00002018-200427120-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15366976/\">https://pubmed.ncbi.nlm.nih.gov/15366976</a></p></li><li><p>Akerlund, M, et al., &amp; Trojnar, J (1986). Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women. <i>British journal of obstetrics and gynaecology</i> 93(1) 22–27. DOI:<a href=\"https://doi.org/10.1111/j.1471-0528.1986.tb07807.x\">10.1111/j.1471-0528.1986.tb07807.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3942702/\">https://pubmed.ncbi.nlm.nih.gov/3942702</a></p></li><li><p>Radó, JP, et al., &amp; Fischer, J (1976). The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man. <i>International journal of clinical pharmacology and biopharmacy</i> 13(3) 199–209. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/950263/\">https://pubmed.ncbi.nlm.nih.gov/950263</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Lypressin;
